饾悊饾惀饾惃饾悰饾悮饾惀 Ultomiris 饾悓饾悮饾惈饾悿饾悶饾惌 Competitive Intelligence & Emerging Opportunities
The Ultomiris Drug Market is experiencing significant growth due to the increasing prevalence of rare autoimmune and hematologic disorders, rising awareness about complement-mediated diseases, and advancements in biologic therapies. Ultomiris (ravulizumab), a long-acting complement C5 inhibitor, has emerged as a breakthrough treatment for several life-threatening conditions, driving...
0 Commentarios 0 Acciones 51 Views 0 Vista previa